Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
46
SQNS Quote, Financials, Valuation and Earnings
Last price:
$3.01
Seasonality move
:
-2.31%
Day range:
$3.50 - $4.96
52-week range:
$1.15 - $5.83
Dividend yield:
0%
P/E ratio:
16.68x
P/S ratio:
2.69x
P/B ratio:
11.18x
Volume:
7.1M
Avg. volume:
7.3M
1-year change:
221.6%
Market cap:
$550.9M
Revenue:
$36.8M
EPS (TTM):
$0.23
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $50.9M | $50.9M | $60.6M | $33.6M | $36.8M | |
| Revenue Growth (YoY) | 64.97% | -0.07% | 19.01% | -44.48% | 9.56% | |
| Cost of Revenues | $27.5M | $23.7M | $17.7M | $9.5M | $9.1M | |
| Gross Profit | $23.5M | $27.2M | $42.9M | $24.1M | $27.7M | |
| Gross Profit Margin | 46.06% | 53.44% | 70.82% | 71.81% | 75.31% | |
| R&D Expenses | $30.9M | $26.4M | $26.6M | $26.1M | $28.5M | |
| Selling, General & Admin | $17.3M | $19.1M | $20.1M | $27.9M | $26.2M | |
| Other Inc / (Exp) | -$14.4M | $10M | $8.4M | $2.8M | $110.9M | |
| Operating Expenses | $48.2M | $45.5M | $46.7M | $54M | $54.7M | |
| Operating Income | -$24.7M | -$18.3M | -$3.8M | -$29.8M | -$27M | |
| Net Interest Expenses | $14.5M | $11.3M | $10.9M | $11.2M | $22.9M | |
| EBT. Incl. Unusual Items | -$53.6M | -$19.6M | -$6.3M | -$38.3M | $61.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $936K | $625K | $2.7M | $2.7M | $3.5M | |
| Net Income to Company | -$53.6M | -$19.6M | -$6.3M | -$38.3M | $61.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$54.5M | -$20.3M | -$9M | -$41M | $57.6M | |
| Basic EPS (Cont. Ops) | -$4.80 | -$1.40 | -$0.50 | -$1.80 | $2.30 | |
| Diluted EPS (Cont. Ops) | -$4.80 | -$1.40 | -$0.50 | -$1.80 | $2.00 | |
| Weighted Average Basic Share | $11.2M | $14.7M | $18.5M | $22.5M | $24.8M | |
| Weighted Average Diluted Share | $11.2M | $14.7M | $18.5M | $22.5M | $28.4M | |
| EBITDA | -$29.9M | $1.5M | $15.7M | -$15.9M | $148.1M | |
| EBIT | -$39.7M | -$9.1M | $3.6M | -$27.9M | $84.1M | |
| Revenue (Reported) | $50.9M | $50.9M | $60.6M | $33.6M | $36.8M | |
| Operating Income (Reported) | -$24.7M | -$18.3M | -$3.8M | -$29.8M | -$27M | |
| Operating Income (Adjusted) | -$39.7M | -$9.1M | $3.6M | -$27.9M | $84.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.3M | $13.9M | $11.9M | $6M | $8.1M | |
| Revenue Growth (YoY) | 40.46% | 12.74% | -14.34% | -49.35% | 33.63% | |
| Cost of Revenues | $6.1M | $4.4M | $2.6M | $2.2M | $2.9M | |
| Gross Profit | $6.2M | $9.5M | $9.3M | $3.9M | $5.2M | |
| Gross Profit Margin | 50.14% | 68.07% | 78.52% | 63.95% | 64.45% | |
| R&D Expenses | $7.3M | $6.4M | $7.5M | $6.6M | $7.2M | |
| Selling, General & Admin | $4.8M | $5M | $5.9M | $5.8M | $4.8M | |
| Other Inc / (Exp) | -$2.7M | $6.8M | $2.1M | $228K | -$517K | |
| Operating Expenses | $12M | $11.4M | $13.3M | $12.4M | $12M | |
| Operating Income | -$5.8M | -$2M | -$4M | -$8.5M | -$6.8M | |
| Net Interest Expenses | $2.7M | $2.7M | $2.5M | $3.3M | -- | |
| EBT. Incl. Unusual Items | -$11.3M | $2.1M | -$4.4M | -$11.6M | -$7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $147K | $104K | $666K | $167K | $281K | |
| Net Income to Company | -$11.3M | $2.1M | -$4.4M | -$11.6M | -$7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.4M | $2M | -$5M | -$11.8M | -$7.3M | |
| Basic EPS (Cont. Ops) | -$0.83 | $0.13 | -$0.25 | -$0.48 | -$0.29 | |
| Diluted EPS (Cont. Ops) | -$0.83 | $0.10 | -$0.25 | -$0.48 | -$0.29 | |
| Weighted Average Basic Share | $13.9M | $16.5M | $19.4M | $24.6M | $25.2M | |
| Weighted Average Diluted Share | $13.9M | $18.4M | $19.4M | $24.6M | $25.2M | |
| EBITDA | -$3.1M | $428K | -$241K | -$6.2M | -$5.2M | |
| EBIT | -$5.8M | -$2M | -$4M | -$8.5M | -$6.8M | |
| Revenue (Reported) | $12.3M | $13.9M | $11.9M | $6M | $8.1M | |
| Operating Income (Reported) | -$5.8M | -$2M | -$4M | -$8.5M | -$6.8M | |
| Operating Income (Adjusted) | -$5.8M | -$2M | -$4M | -$8.5M | -$6.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $54.5M | $52.4M | $58.6M | $27.7M | $38.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $29.3M | $22M | $15.8M | $9.1M | $9.8M | |
| Gross Profit | $25.1M | $30.5M | $42.8M | $18.7M | $29.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $30.7M | $25.6M | $27.6M | $25.2M | $29.1M | |
| Selling, General & Admin | $17.2M | $19.4M | $21M | $27.8M | $25.2M | |
| Other Inc / (Exp) | -$13.6M | $19.5M | $3.8M | $846K | $110.2M | |
| Operating Expenses | $47.9M | $44.9M | $48.6M | $53M | $54.3M | |
| Operating Income | -$22.7M | -$14.5M | -$5.9M | -$34.4M | -$25.3M | |
| Net Interest Expenses | $13.7M | $11.2M | $10.7M | $12M | $19.2M | |
| EBT. Incl. Unusual Items | -$50M | -$6.2M | -$12.8M | -$45.6M | $65.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $640K | $582K | $3.3M | $2.2M | $3.7M | |
| Net Income to Company | -$50M | -$6.2M | -$12.8M | -$45.6M | $65.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$50.6M | -$6.8M | -$16.1M | -$47.7M | $62.1M | |
| Basic EPS (Cont. Ops) | -$4.22 | -$0.48 | -$0.83 | -$1.68 | $0.30 | |
| Diluted EPS (Cont. Ops) | -$4.22 | -$0.51 | -$0.83 | -$1.68 | $0.23 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$12.4M | -$4.3M | $15M | -$21.9M | $149.2M | |
| EBIT | -$22.7M | -$14.5M | $1.6M | -$32.4M | $85.8M | |
| Revenue (Reported) | $54.5M | $52.4M | $58.6M | $27.7M | $38.9M | |
| Operating Income (Reported) | -$22.7M | -$14.5M | -$5.9M | -$34.4M | -$25.3M | |
| Operating Income (Adjusted) | -$22.7M | -$14.5M | $1.6M | -$32.4M | $85.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.3M | $13.9M | $11.9M | $6M | $8.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.1M | $4.4M | $2.6M | $2.2M | $2.9M | |
| Gross Profit | $6.2M | $9.5M | $9.3M | $3.9M | $5.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $7.3M | $6.4M | $7.5M | $6.6M | $7.2M | |
| Selling, General & Admin | $4.8M | $5M | $5.9M | $5.8M | $4.8M | |
| Other Inc / (Exp) | -$2.7M | $6.8M | $2.1M | $228K | -$517K | |
| Operating Expenses | $12M | $11.4M | $13.3M | $12.4M | $12M | |
| Operating Income | -$5.8M | -$2M | -$4M | -$8.5M | -$6.8M | |
| Net Interest Expenses | $2.7M | $2.7M | $2.5M | $3.3M | -- | |
| EBT. Incl. Unusual Items | -$11.3M | $2.1M | -$4.4M | -$11.6M | -$7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $147K | $104K | $666K | $167K | $281K | |
| Net Income to Company | -$11.3M | $2.1M | -$4.4M | -$11.6M | -$7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.4M | $2M | -$5M | -$11.8M | -$7.3M | |
| Basic EPS (Cont. Ops) | -$0.83 | $0.13 | -$0.25 | -$0.48 | -$0.29 | |
| Diluted EPS (Cont. Ops) | -$0.83 | $0.10 | -$0.25 | -$0.48 | -$0.29 | |
| Weighted Average Basic Share | $13.9M | $16.5M | $19.4M | $24.6M | $25.2M | |
| Weighted Average Diluted Share | $13.9M | $18.4M | $19.4M | $24.6M | $25.2M | |
| EBITDA | -$3.1M | $428K | -$241K | -$6.2M | -$5.2M | |
| EBIT | -$5.8M | -$2M | -$4M | -$8.5M | -$6.8M | |
| Revenue (Reported) | $12.3M | $13.9M | $11.9M | $6M | $8.1M | |
| Operating Income (Reported) | -$5.8M | -$2M | -$4M | -$8.5M | -$6.8M | |
| Operating Income (Adjusted) | -$5.8M | -$2M | -$4M | -$8.5M | -$6.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.6M | $4.8M | $5.7M | $5.7M | $9.1M | |
| Short Term Investments | $10.9M | -- | $5M | -- | $53M | |
| Accounts Receivable, Net | $17.3M | $13.6M | $8.5M | $8.1M | $4.8M | |
| Inventory | $6.2M | $6.4M | $9.4M | $6.3M | $2.9M | |
| Prepaid Expenses | $962K | $2.1M | $1.4M | $1.4M | $1.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $51.7M | $40.9M | $40.4M | $36.9M | $93M | |
| Property Plant And Equipment | $9.2M | $8M | $8.5M | $6.8M | $4.3M | |
| Long-Term Investments | $386K | $357K | $337K | $360K | $353K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $25.3M | $38M | $48.7M | $64.3M | $5.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $87.2M | $89.6M | $98.8M | $109.2M | $106.5M | |
| Accounts Payable | $15.7M | $13.9M | $9.3M | $16.3M | $6.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $9.3M | $2.9M | $10.9M | $74.6M | $9M | |
| Current Portion Of Capital Lease Obligations | $1M | $1.2M | $1.3M | $1.5M | $1.4M | |
| Other Current Liabilities | $963K | $1.2M | $781K | $1.5M | $2.3M | |
| Total Current Liabilities | $62.5M | $48.7M | $36.8M | $107.9M | $42.2M | |
| Long-Term Debt | $51.2M | $53.8M | $52M | $2.9M | $5.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $124M | $113.9M | $96.7M | $115.2M | $51.2M | |
| Common Stock | $3.3M | $3.7M | $2.3M | $2.9M | $2.9M | |
| Other Common Equity Adj | $46.7M | $57.2M | $62.9M | $70.3M | $74.5M | |
| Common Equity | -$36.8M | -$24.3M | $2.1M | -$6.1M | $55.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$36.8M | -$24.3M | $2.1M | -$6.1M | $55.4M | |
| Total Liabilities and Equity | $87.2M | $89.6M | $98.8M | $109.2M | $106.5M | |
| Cash and Short Terms | $18.5M | $4.8M | $10.7M | $5.7M | $62.1M | |
| Total Debt | $74.7M | $66.2M | $62.9M | $77.6M | $14.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $13.5M | $9.8M | $5.3M | $474K | $11.9M | |
| Short Term Investments | -- | $16.5M | -- | -- | $34M | |
| Accounts Receivable, Net | $7.1M | $5.6M | $3.6M | $6.9M | $3.5M | |
| Inventory | $4.6M | $7.5M | $8.6M | $5.2M | $3M | |
| Prepaid Expenses | $1.2M | $2.2M | $1.9M | $1.9M | $1.8M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $39.8M | $56.4M | $32.4M | $28.5M | $75.8M | |
| Property Plant And Equipment | $9.1M | $7.7M | $7.7M | $6.2M | $4.7M | |
| Long-Term Investments | $369K | $350K | $343K | $353K | $402K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $80.4M | $110.9M | $92.7M | $113.4M | $97.6M | |
| Accounts Payable | $14.7M | $11.4M | $11.6M | $18.5M | $8.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $23.1M | $15.5M | $10.5M | $83.4M | $4.8M | |
| Current Portion Of Capital Lease Obligations | $1.2M | $1.3M | $1.3M | $1.3M | $1.4M | |
| Other Current Liabilities | $9.5M | $8.3M | $9.3M | $9.2M | $12.4M | |
| Total Current Liabilities | $61.4M | $40.7M | $35.9M | $115.7M | $39.1M | |
| Long-Term Debt | $41.2M | $49.8M | $52M | $10.8M | $4.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $110.1M | $101.9M | $94M | $130.2M | $48.3M | |
| Common Stock | $3.5M | $4.6M | $2.3M | $2.9M | $3M | |
| Other Common Equity Adj | $53.2M | $58.5M | $64.7M | $71.5M | $75.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$29.7M | $9M | -$1.3M | -$16.8M | $49.3M | |
| Total Liabilities and Equity | $80.4M | $110.9M | $92.7M | $113.4M | $97.6M | |
| Cash and Short Terms | $13.5M | $26.3M | $5.3M | $474K | $45.9M | |
| Total Debt | $64.4M | $65.3M | $62.5M | $94.2M | $9.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$53.6M | -$19.6M | -$6.3M | -$38.3M | $61.1M | |
| Depreciation & Amoritzation | $9.8M | $10.6M | $12M | $11.9M | $64M | |
| Stock-Based Compensation | $3M | $5.1M | $5.5M | $7.1M | $4.1M | |
| Change in Accounts Receivable | -$9.3M | -$2.3M | $5.1M | -$3.2M | $1.6M | |
| Change in Inventories | $439K | -$208K | -$3M | $3.1M | $3.1M | |
| Cash From Operations | -$19.4M | -$8.5M | -$1.8M | -$7.3M | -$19.5M | |
| Capital Expenditures | $13.8M | $28.9M | $22.7M | $29.6M | $19.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$24.8M | -$19.7M | -$26M | -$24.4M | $93.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $17.8M | $39.7M | $3M | $11M | $18.3M | |
| Long-Term Debt Repaid | -$7M | -$19M | -$3M | -$3.4M | -$82.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $37.6M | $25.4M | $28.7M | $31.7M | -$70.8M | |
| Beginning Cash (CF) | $14.1M | $7.6M | $4.8M | $5.7M | $5.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$6.5M | -$2.7M | $829K | $38K | $3.4M | |
| Ending Cash (CF) | $7.6M | $4.8M | $5.7M | $5.7M | $9.1M | |
| Levered Free Cash Flow | -$33.2M | -$37.4M | -$24.5M | -$36.8M | -$39.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.3M | $2.1M | -$4.4M | -$11.6M | -$7M | |
| Depreciation & Amoritzation | $2.8M | $2.4M | $3.8M | $2.3M | $1.7M | |
| Stock-Based Compensation | $1.2M | $1.3M | $1.8M | $1.1M | $1M | |
| Change in Accounts Receivable | $10.5M | $7.6M | $2.3M | $509K | $885K | |
| Change in Inventories | $1.6M | -$1.1M | $835K | $1.1M | -$103K | |
| Cash From Operations | $9.2M | -$2.7M | $3.5M | -$3.3M | -$9.4M | |
| Capital Expenditures | $5.9M | $5.5M | $6.6M | $10.7M | $461K | |
| Cash Acquisitions | -- | -- | -- | -- | -$1.1M | |
| Cash From Investing | $2.3M | -$21.9M | -$1.6M | -$10.6M | $18M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $359K | $545K | $9M | -- | |
| Long-Term Debt Repaid | -$5.2M | -$597K | -$2.4M | -$1.1M | -$1.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$5.6M | $29.6M | -$2.3M | $8.6M | -$5.7M | |
| Beginning Cash (CF) | $7.6M | $4.8M | $5.7M | $5.7M | $9.1M | |
| Foreign Exchange Rate Adjustment | $10K | -$2K | $4K | -$4K | $2K | |
| Additions / Reductions | $5.9M | $5M | -$331K | -$5.2M | $2.9M | |
| Ending Cash (CF) | $13.5M | $9.8M | $5.3M | $474K | $11.9M | |
| Levered Free Cash Flow | $3.3M | -$8.2M | -$3.1M | -$14M | -$9.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$50M | -$6.2M | -$12.8M | -$45.6M | $65.8M | |
| Depreciation & Amoritzation | $10.3M | $10.2M | $13.4M | $10.5M | $63.4M | |
| Stock-Based Compensation | $3.5M | $5.3M | $5.9M | $6.4M | $4M | |
| Change in Accounts Receivable | $3.4M | -$5.3M | -$111K | -$5.1M | $1.9M | |
| Change in Inventories | $1.5M | -$2.9M | -$1M | $3.3M | $1.9M | |
| Cash From Operations | -$2.5M | -$20.4M | $4.3M | -$14M | -$25.6M | |
| Capital Expenditures | $17.3M | $28.5M | $23.8M | $33.7M | $9.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -$1.1M | |
| Cash From Investing | -$20M | -$43.9M | -$5.7M | -$33.5M | $122.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $40.1M | $3.2M | $19.5M | $9.3M | |
| Long-Term Debt Repaid | -$10.9M | -$14.4M | -$4.8M | -$2M | -$82.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $30.8M | $60.7M | -$3.1M | $42.6M | -$85.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.3M | -$3.7M | -$4.5M | -$4.9M | $11.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$19.8M | -$48.9M | -$19.4M | -$47.7M | -$35.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.3M | $2.1M | -$4.4M | -$11.6M | -$7M | |
| Depreciation & Amoritzation | $2.8M | $2.4M | $3.8M | $2.3M | $1.7M | |
| Stock-Based Compensation | $1.2M | $1.3M | $1.8M | $1.1M | $1M | |
| Change in Accounts Receivable | $10.5M | $7.6M | $2.3M | $509K | $885K | |
| Change in Inventories | $1.6M | -$1.1M | $835K | $1.1M | -$103K | |
| Cash From Operations | $9.2M | -$2.7M | $3.5M | -$3.3M | -$9.4M | |
| Capital Expenditures | $5.9M | $5.5M | $6.6M | $10.7M | $461K | |
| Cash Acquisitions | -- | -- | -- | -- | -$1.1M | |
| Cash From Investing | $2.3M | -$21.9M | -$1.6M | -$10.6M | $18M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $359K | $545K | $9M | -- | |
| Long-Term Debt Repaid | -$5.2M | -$597K | -$2.4M | -$1.1M | -$1.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$5.6M | $29.6M | -$2.3M | $8.6M | -$5.7M | |
| Beginning Cash (CF) | $7.6M | $4.8M | $5.7M | $5.7M | $9.1M | |
| Foreign Exchange Rate Adjustment | $10K | -$2K | $4K | -$4K | $2K | |
| Additions / Reductions | $5.9M | $5M | -$331K | -$5.2M | $2.9M | |
| Ending Cash (CF) | $13.5M | $9.8M | $5.3M | $474K | $11.9M | |
| Levered Free Cash Flow | $3.3M | -$8.2M | -$3.1M | -$14M | -$9.8M | |
Get SQNS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SQNS
Sector
P/E ratio
16.68x
23.84x
PEG ratio
-0.01x
0.00x
P/B ratio
11.18x
2.31x
Price / LTM sales
2.69x
1.64x
Growth Metrics
SQNS
Sector
Revenue growth
33.63%
3.84%
Earnings growth
--
10.8%
Revenue (5-year growth)
3.6%
6.27%
Earnings forecast
-$0.27
$0.12
Profitability
SQNS
Sector
Profitability FY 2024
$27.7M
$77.3M
Return on invested capital
69.34%
0.05%
Return on assets
46.91%
-0.48%
Return on equity
240.01%
0.73%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
22
Estimated Next Earnings Date
Aug
5
Balance Sheet
SQNS
Sector
Total cash
$45.9M
$48.7M
Short term investments
$53M
$19.4M
Total assets
$106.5M
$223.8M
Long term debt
$9.5M
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
